LexDanaLexDanabeta
Inventor

Edward M. Rudnic

Inventor
North Potomac, MD, US

Overview

55→
Patents
1986–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes75%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61JContainers specially adapted for medical or pharmaceutical purposes1%
B09BDisposal of solid waste not otherwise provided for1%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers1%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,532,385Disposal of medicaments20208,889,187'Once a day amoxicillin product comprising immediate and delayed release dosage forms'20148,303,988'Antifungal once-a-day product, use and formulation thereof'2012RE042096'Oral pulsed dose drug delivery system'2011RE041148'Oral pulsed dose drug delivery system'20107,282,221'Antiviral product, use and formulation thereof'20077,157,095'Multiple-delayed release antifungal product, use and formulation thereof'20077,122,204'Antibiotic composition with inhibitor'20067,108,859'Antineoplastic product, use and formulation thereof'20067,105,174'Multiple-delayed release anti-neoplastic product, use and formulation thereof'20067,074,417'Multiple-delayed release anti-viral product, use and formulation thereof'20067,025,989'Multiple-delayed released antibiotic product, use and formulation thereof'20066,991,807'Antibiotic composition'20066,984,401'Antiviral product, use and formulation thereof'20066,929,804'Anti-fungal composition'20056,814,979'Osmotic drug delivery system'20046,730,320'Tetracycline antibiotic product, use and formulation thereof'20046,723,341'Antibiotic product, use and formulation thereof'20046,692,767'Solid solution beadlet'20046,669,948'Antibiotic product, use and formulation thereof'20036,667,057'Levofloxacin antibiotic product, use and formulation thereof'20036,667,042'Fluroquinilone antibiotic product, use and formulation thereof'20036,663,891'Erythromyacin antibiotic product, use and formulation thereof'20036,663,890'Metronidazole antibiotic product, use and formulation thereof'20036,638,532'Tetracyclinedoxycycline antibiotic composition'20036,632,453'Ciprofoxacin-metronidazole antibiotic composition'20036,627,222'Amoxicillin-dicloxacillin antibiotic composition'20036,623,758'Cephalosporin-metronidazole antibiotic composition'20036,623,757'Antibiotic composition'20036,610,328'Amoxicillin-clarithromycin antibiotic composition'20036,605,300'Oral pulsed dose drug delivery system'20036,565,882'Antibiotic composition with inhibitor'20036,544,555'Antibiotic product, use and formulation thereof'20036,541,014'Antiviral product, use and formulation thereof'20036,514,532'Soluble form osmotic dose delivery system'20036,361,796'Soluble form osmotic dose delivery system'20026,322,819'Oral pulsed dose drug delivery system'20016,284,276'Soluble form osmotic dose delivery system'20016,110,498'Osmotic drug delivery system'20005,952,004'Emulsified drug delivery systems'19995,912,013'Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine'19995,897,876'Emulsified drug delivery system'19995,883,103'Oral acyclovir delivery'19995,824,638'Oral insulin delivery'19985,484,608'Sustained-release drug delivery system'19965,447,729'Multilamellar drug delivery systems'19955,430,021'Hydrophobic drug delivery systems'19955,326,570'Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine'19945,262,165'Transdermal nitroglycerin patch with penetration enhancers'19935,186,930'Sustained release oral suspensions'19935,035,898'Potassium/magnesium supplement'19914,999,189'Sustained release oral suspensions'19914,666,705'Controlled release formulation'19874,610,870'Controlled release formulation'19864,575,539'Drug delivery systems including novel interpenetrating polymer networks and method'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–1987Patents assigned to SQUIBB & SONS INC (3)· patent assignee history
1986–1987Based in Kendall Park, NJ, US· patent location history
1991–1993Patents assigned to SCHERING CORP (4)· patent assignee history
1991–1993Based in Boca Raton, FL, US· patent location history
1994–1996Patents assigned to PHARMAVENE INC (4)· patent assignee history
1994Based in Gaithersburg, MD, US· patent location history
1995–2020Based in Potomac, MD, US· patent location history
1998–2004Patents assigned to SHIRE LAB INC (13)· patent assignee history
1998–2014Based in North Potomac, MD, US· patent location history
2003–2007Patents assigned to ADVANCIS PHARMACEUTICAL CORP (25)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ADVANCIS PHARMACEUTICAL CORP252003–2007
SHIRE LAB INC131998–2004
PHARMAVENE INC41994–1996
SCHERING CORP41991–1993
SQUIBB & SONS INC31986–1987
Locations
LocationPatentsSpan
North Potomac, Maryland, US401998–2014
Potomac, Maryland, US71995–2020
Boca Raton, Florida, US41991–1993
Kendall Park, New Jersey, US21986–1987
Gaithersburg, Maryland, US11994